Quanterix Corporation QTRX Simoa — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Quanterix Corporation in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Quanterix Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Quanterix Corporation's simoa — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Quanterix Corporation's simoa — total revenues?
- Quanterix Corporation (QTRX) reported simoa — total revenues of $6.68M in Q1 2026.
- How has Quanterix Corporation's simoa — total revenues changed year-over-year?
- Quanterix Corporation's simoa — total revenues decreased by 24.3% year-over-year, from $8.82M to $6.68M.
- What does simoa — total revenues mean?
- This metric represents the total gross revenue generated from the sale of products, assay kits, and associated services within the company's proprietary ultra-sensitive digital immunoassay platform segment. It serves as a primary indicator of market adoption and commercial traction for the company's core precision health technology. Tracking this revenue stream helps investors evaluate the segment's contribution to overall corporate growth and its competitive positioning in the life sciences research and diagnostics market.